SCHEMBL3884061

SCHEMBL3884061

COC(=O)CCc1ccc(OCCc2ccc(Cl)cc2)c(-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
NR4A2 P43354 2/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
ENPP2 Q13822 1/20 0.38
FLT3 P36888 1/20 0.38
FFAR1 O14842 1/20 0.38
PTPN1 P18031 1/20 0.38
MAP3K11 Q16584 1/20 0.38
CNR2 P34972 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
TP53 P04637 2/20 0.37
MDM2 Q00987 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CDK1 P06493 1/20 0.36
KDR P35968 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3882445 0.93 HDAC1 (0.41) MAPTNR4A2HDAC1ENPP2FFAR1
SCHEMBL3884149 0.92 CDK8 (0.41) MAPTNR4A2HDAC1ENPP2FLT3
SCHEMBL3887874 0.91 ENPP2 (0.43) MAPTHDAC1HDAC8ENPP2FFAR1
SCHEMBL27627113 0.91 ENPP2 (0.48) HDAC1HDAC8ENPP2PTPN1TP53
SCHEMBL3882078 0.91 HDAC1 (0.39) HDAC1HDAC8ENPP2FLT3PTPN1
SCHEMBL3883394 0.91 FLT3 (0.42) HDAC1HDAC8ENPP2FLT3FFAR1
SCHEMBL3884999 0.89 FFAR1 (0.49) ENPP2FFAR1TP53MDM2
SCHEMBL3884677 0.88 KMT2A (0.42) MAPTHDAC1ENPP2FLT3FFAR1
SCHEMBL3882480 0.88 CCNC (0.46) HDAC1HDAC8ENPP2PTPN1CYP1A2
SCHEMBL3882301 0.87 HDAC1 (0.41) HDAC1HDAC8ENPP2PTPN1MAP3K11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 MAPT 4799/4885NR4A2 1500/4885HDAC1 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.